Intelligent Bio Solutions Inc. (NASDAQ: INBS) is 495.30% higher on its value in year-to-date trading and has touched a low of $0.17 and a high of $1.60 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The INBS stock was last observed hovering at around $1.03 in the last trading session, with the day’s gains setting it 0.16% off its average median price target of $1.60 for the next 12 months. It is also 25.63% off the consensus price target high of $1.60 offered by 1 analysts, but current levels are 25.63% higher than the price target low of $1.60 for the same period.
Currently trading at $1.19, the stock is 318.93% and 257.86% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 30.17 million and changing 15.53% at the moment leaves the stock 116.08% off its SMA200. INBS registered -19.05% loss for a year compared to 6-month loss of 70.00%. The firm has a 200-day simple moving average (SMA200) of $0.12.
The stock witnessed a 313.63% gain in the last 1 month and extending the period to 3 months gives it a 161.48%, and is 340.74% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 28.37% over the week and 20.00% over the month.
Intelligent Bio Solutions Inc. (INBS) has around 12 employees, a market worth around $20.90M and $0.70M in sales. Distance from 52-week low is 600.00% and -25.62% from its 52-week high. The company has generated returns on investments over the last 12 months (-126.30%).
Intelligent Bio Solutions Inc. (INBS) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Intelligent Bio Solutions Inc. (INBS) is a “Buy”. 1 analysts offering their recommendations for the stock have an average rating of 1.00, where 0 rate it as a Hold and 0 think it is a “Overweight”. 1 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Intelligent Bio Solutions Inc. is expected to release its quarterly report on 05/09/2023.The EPS is expected to grow by 16.20% this year.
Intelligent Bio Solutions Inc. (INBS) Top Institutional Holders
The shares outstanding are 14.89M, and float is at 14.74M with Short Float at 0.75%.
Intelligent Bio Solutions Inc. (INBS) Insider Activity
A total of 7 insider transactions have happened at Intelligent Bio Solutions Inc. (INBS) in the last six months, with sales accounting for 0 and purchases happening 7 times.